Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Epirubicin hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Epirubicin 100mg/50ml solution for infusion vials
0801020N0AAAGAG
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg powder for solution for injection vials
0801020N0AAAAAA
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 10mg/5ml solution for injection vials
0801020N0AAADAD
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 200mg/100ml solution for infusion vials
0801020N0AAAFAF
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg powder for solution for injection vials
0801020N0AAABAB
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 20mg/10ml solution for injection vials
0801020N0AAAIAI
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg powder for solution for injection vials
0801020N0AAACAC
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Epirubicin 50mg/25ml solution for injection vials
0801020N0AAAEAE
|
Epirubicin hydrochloride | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 10mg/5ml solution for injection Cytosafe vials
0801020N0BBADAD
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 200mg/100ml inf Cytosafe vials
0801020N0BBAFAF
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin 50mg/25ml inj Cytosafe vials
0801020N0BBAEAE
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 10mg inj vials
0801020N0BBAAAA
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 20mg inj vials
0801020N0BBABAB
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Pharmorubicin Rapid Dissolution 50mg inj vials
0801020N0BBACAC
|
Pharmorubicin | Epirubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.